Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseases
Constanza Vargas, Stephen Goodall, Deborah J Street, Manuel Espinoza, Richard De Abreu Lourenço · 2025
Read Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseases by Constanza Vargas, Stephen Goodall, Deborah J Street, Manuel Espinoza, Richard De Abreu Lourenço (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751238.txt.
Description
Constanza Vargas and co-authors ask ordinary Australians what society should pay for when a rare disease drug comes begging. Rare diseases are individually uncommon but collectively common, and their drugs arrive with thin evidence and thick price tags. Their 2025 paper runs a discrete choice experiment: over a thousand respondents, cast as government advisors, repeatedly chose which of two drugs to fund.
The choices varied the certainty of the evidence, the unmet need, the size of the health and quality-of-life gains, and the cost to government. Respondents generally favored drugs that extend survival, those whose benefit they could trust, and those restoring patients' ability to do their usual activities. Statistical models sorted how different groups traded these values against each other and against money. The authors give funding bodies a map of the public values their frameworks claim to serve.
Catalog record
| CREATOR | Constanza Vargas, Stephen Goodall, Deborah J Street, Manuel Espinoza, Richard De Abreu Lourenço |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |